HFF has logged approximately $7.3* billion
in transaction volume (across all platforms) in the life science field, which includes biotech manufacturing and lab research.
HFF has secured $3.7* billion
in financing for life science facilities across the United States.
HFF has sold approximately $3.2* billion
of life science facilities across the United States.
HFF has strong relationships with the top players in the life science field: the Abbey Group, Alexandria Real Estate Equities, Beacon Capital Partners, BioMed Realty Trust, the Davis Companies, Fallon Company/Mass Mutual, King Street Properties, Marcus Partners, MIT, National Development, Novartis, Praecis Pharmaceuticals, RREEF, and Spaulding & Slye Investors.
HFF has a firmly established presence in the strongest life science markets in the United States: Boston/Cambridge, Gaithersburg/Rockville (Washington, D.C.), San Diego, and the San Francisco Bay Area
* Includes some transactions closed by team members prior to joining HFF.
|Life Science Team
|HFF Life Science Expertise Team